Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$705,752.00
Jul 1, 2015
Characterization of a novel clinical marker of endometriosis.
$332,954.00
Jul 1, 2015
CYCLE Pilot: A multi-centre pilot randomized clinical trial of early in-bed leg cycling versus routine physiotherapy in mechanically ventilated patients
$100,000.00
Jul 1, 2015
Bridging discovery to clinic: from biomarkers to therapeutic developments in ovarian cancer
$100,000.00
Jul 1, 2015
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness (BALANCE): A Randomized Controlled Clinical Trial
$300,000.00
Jul 1, 2015
Statistical integration of biomarker data leads to a new understanding of aging, with direct clinical implications
$596,450.00
Jul 1, 2015
Elucidating mechanisms of MSC-induced tissue regeneration: path to mesenchymal stromal cell clinical trial in glaucoma
$512,179.00
Jul 1, 2015
Reassessment of Anti-Platelet therapy using InDividualized Strategies -Ticagrelor in Patients with Acute Coronary Syndromes Treated by Coronary Artery Bypass Graft Surgery - A Pharmacodynamic and Clinical Study to Decrease Bleeding Risks and Ischemic Complications - The RAPID-TITRATE CABG study
$2,309,111.00
Jul 1, 2015
Clinical translation of genomic understanding of cardiometabolic risk
$605,911.00
Jul 1, 2015
Investigating electroretinography(ERG) as a new method for predicting conversion to psychosis in youth at clinical high risk.
$60,000.00
Jul 1, 2015
Mendelian randomization: Testing the causality of clinically-relevant biomarkers